BioVie Inc. (BIVI) NASDAQ
$0.49 (0) (-0.39%)
Market Cap: $19.42M
As of 04/19/24 04:00 PM EDT. Market closed.
BioVie Inc. (BIVI)
NASDAQ
$0.49
(0) (-0.39%)
Market Cap: $19.42M
As of 04/19/24 04:00 PM EDT. Market closed.
biovie inc. (otc pink: bivi) is developing novel drug therapies for life-threatening complications of chronic liver disease. our initial target is ascites, which can occur in patients with advanced cirrhosis due to hepatitis, nash (non-alcoholic steatohepatitis), or alcoholism. ascites affects about 100,000 americans and carries an estimated 40% mortality rate within two years of being diagnosed. ... read more
biovie inc. (otc pink: bivi) is developing novel drug therapies for life-threatening complications of chronic liver disease. our initial target is ascites, which can occur in patients with advanced cirrhosis due to hepatitis, nash (non-alcoholic steatohepatitis), or alcoholism. ascites affects about 100,000 americans and carries an estimated 40% mortality rate within two years of being diagnosed. the company’s new drug candidate biv201 is about to enter a phase 2 clinical trial in the us. it’s based on a drug (terlipressin) not yet available in the us, but approved in about 40 countries for treating related complications of liver cirrhosis. the fda has never approved a drug to treat ascites and there is a significant unmet medical need for our novel therapy, which has orphan drug status. biovie has attracted funding from strategic investors including aspire capital, cuong do, the global strategy lead for samsung, and hari kumar, founder of adheron therapeutics which he sold to roche fo read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
GORLIN STEVE | Director | Dec 01, 2023 | Sale | $1.69 | 75,680 | 127,899 | 46,358 | Dec 06, 2023, 04:16 PM |
DO CUONG V | President & CEO | Nov 30, 2023 | Buy | $1.78 | 10,000 | 17,800 | 68,759 | Dec 01, 2023, 06:26 PM |
GORLIN STEVE | Director | Sep 05, 2023 | Sale | $3.05 | 8,560 | 26,108 | 75,680 | Sep 07, 2023, 06:20 PM |
BERMAN RICHARD J | Director | Aug 22, 2023 | Sale | $3.50 | 10,805 | 37,827 | 16,789 | Aug 24, 2023, 08:33 PM |
BERMAN RICHARD J | Director | Jun 07, 2023 | Sale | $5.81 | 5,984 | 34,782 | 23,210 | Jun 15, 2023, 05:15 PM |
BERMAN RICHARD J | Director | May 22, 2023 | Sale | $6.50 | 5,000 | 32,506 | 29,194 | Jun 15, 2023, 05:15 PM |
BERMAN RICHARD J | Director | Mar 28, 2023 | Sale | $8.52 | 7,613 | 64,870 | 36,807 | Apr 06, 2023, 09:02 PM |
BERMAN RICHARD J | Director | Mar 27, 2023 | Sale | $8.52 | 3,371 | 28,711 | 41,807 | Apr 06, 2023, 09:02 PM |
Palumbo Joseph M | Chief Medical Officer | Feb 16, 2023 | Option Exercise | $6.12 | 2,476 | 15,153 | 37,148 | Feb 22, 2023, 07:31 PM |
DO CUONG V | CEO & President | Feb 16, 2023 | Option Exercise | $6.12 | 4,953 | 30,312 | 229,895 | Feb 22, 2023, 05:49 PM |
KIM JOANNE WENDY | Chief Financial Officer | Feb 16, 2023 | Option Exercise | $6.12 | 2,476 | 15,153 | 39,148 | Feb 22, 2023, 05:49 PM |
Ahlem Clarence N. | EVP Neuroscience Product Dev. | Feb 16, 2023 | Option Exercise | $6.12 | 2,476 | 15,153 | 37,148 | Feb 22, 2023, 05:48 PM |
READING CHRISTOPHER | EVP Neuroscience R&D | Feb 16, 2023 | Option Exercise | $6.12 | 2,476 | 15,153 | 37,148 | Feb 22, 2023, 05:47 PM |
MARKHAM PENELOPE | EVP Liver Cirrhosis R&D | Feb 16, 2023 | Option Exercise | $6.12 | 2,476 | 15,153 | 47,841 | Feb 22, 2023, 05:47 PM |
PEIZER TERREN S | Director | Jun 24, 2019 | Option Exercise | $45.00 | 1,526,334 | 68,685,030 | 3,127,934 | Aug 26, 2022, 05:10 PM |
PEIZER TERREN S | Director | Sep 22, 2020 | Option Exercise | $0.00 | 1,549,750 | 155 | 11,168,538 | Aug 26, 2022, 05:10 PM |
PEIZER TERREN S | Director | Aug 15, 2022 | Option Exercise | $1.65 | 3,636,364 | 6,000,001 | 23,166,210 | Aug 16, 2022, 05:11 PM |
KIM JOANNE WENDY | CFO | Dec 07, 2021 | Buy | $5.40 | 2,000 | 10,798 | 2,000 | Dec 09, 2021, 04:46 PM |
GORLIN STEVE | Director | Nov 03, 2020 | Buy | $7.95 | 2,430 | 19,318 | 45,100 | Dec 15, 2020, 03:01 PM |
GORLIN STEVE | Director | Oct 30, 2020 | Buy | $7.97 | 2,570 | 20,483 | 42,670 | Dec 15, 2020, 03:00 PM |
GORLIN STEVE | Director | Oct 21, 2020 | Buy | $9.19 | 5,000 | 45,950 | 40,100 | Oct 22, 2020, 03:10 PM |
GORLIN STEVE | Director | Oct 15, 2020 | Buy | $10.19 | 5,100 | 51,967 | 25,100 | Oct 19, 2020, 02:59 PM |
GORLIN STEVE | Director | Oct 15, 2020 | Buy | $10.06 | 10,000 | 100,550 | 35,100 | Oct 19, 2020, 02:59 PM |
GORLIN STEVE | Director | Oct 09, 2020 | Buy | $9.61 | 282 | 2,710 | 20,000 | Oct 14, 2020, 02:07 PM |
GORLIN STEVE | Director | Oct 07, 2020 | Buy | $9.42 | 4,718 | 44,444 | 19,718 | Oct 14, 2020, 02:05 PM |
GORLIN STEVE | Director | Sep 22, 2020 | Buy | $10.00 | 15,000 | 150,000 | 15,000 | Oct 14, 2020, 01:49 PM |
Kumar Hari | Director | Jan 02, 2019 | Option Exercise | $0.04 | 200,000 | 7,000 | 727,272 | Mar 13, 2019, 05:39 PM |
Kumar Hari | Director | Jun 15, 2018 | Option Exercise | $0.02 | 100,000 | 2,000 | 527,272 | Mar 13, 2019, 05:32 PM |
Kumar Hari | Director | Jan 02, 2018 | Option Exercise | $0.15 | 200,000 | 30,000 | 427,272 | Mar 13, 2019, 05:32 PM |
Kumar Hari | Director | Aug 14, 2017 | Option Exercise | $0.22 | 90,908 | 20,000 | 227,272 | Mar 13, 2019, 05:32 PM |
Adams Jonathan M | Chief Operating Officer | Jan 02, 2019 | Option Exercise | $0.04 | 200,000 | 7,000 | 6,303,521 | Feb 05, 2019, 04:05 PM |
Sherman Michael Edward | Director | Jan 02, 2019 | Option Exercise | $0.04 | 200,000 | 7,000 | 718,181 | Feb 05, 2019, 03:58 PM |
Do Cuong V | Director | Jan 02, 2019 | Option Exercise | $0.04 | 200,000 | 7,000 | 2,871,354 | Feb 05, 2019, 03:51 PM |
Sooch Mina | Director | Jan 02, 2019 | Option Exercise | $0.04 | 200,000 | 7,000 | 813,636 | Feb 05, 2019, 03:37 PM |
Lang James Paul | Director | Jan 02, 2019 | Option Exercise | $0.04 | 200,000 | 7,000 | 450,000 | Feb 05, 2019, 02:49 PM |
Adams Jonathan M | Chief Operating Officer | Jul 03, 2018 | Option Exercise | $1.50 | 10,000 | 15,000 | 10,000 | Nov 01, 2018, 03:50 PM |
Do Cuong V | Director | Jul 03, 2018 | Option Exercise | $1.50 | 86,666 | 129,999 | 86,666 | Nov 01, 2018, 03:40 PM |
Lang James Paul | Director | Jul 03, 2018 | Option Exercise | $1.50 | 20,000 | 30,000 | 20,000 | Nov 01, 2018, 03:23 PM |
Lang James Paul | Director | Jan 02, 2018 | Option Exercise | $0.15 | 366,667 | 55,000 | 730,303 | Aug 15, 2018, 03:48 PM |
Lang James Paul | Director | Jul 28, 2017 | Option Exercise | $0.22 | 113,636 | 25,000 | 363,636 | Aug 15, 2018, 03:48 PM |
Sooch Mina | Director | Apr 30, 2018 | Option Exercise | $0.02 | 150,000 | 3,600 | 613,636 | Aug 14, 2018, 06:14 PM |
Sooch Mina | Director | Jan 02, 2018 | Option Exercise | $0.15 | 200,000 | 30,000 | 463,636 | Aug 14, 2018, 06:14 PM |
Do Cuong V | Director | Jan 02, 2018 | Option Exercise | $0.15 | 200,000 | 30,000 | 2,871,354 | Aug 14, 2018, 03:39 PM |
Do Cuong V | Director | Jan 08, 2018 | Option Exercise | $0.15 | 166,667 | 25,000 | 3,038,021 | Aug 14, 2018, 03:39 PM |
Anderson Julie G | Director | May 31, 2018 | Option Exercise | $0.02 | 68,500 | 1,096 | 368,500 | Aug 09, 2018, 07:14 PM |
Anderson Julie G | Director | Jan 02, 2018 | Option Exercise | $0.15 | 200,000 | 30,000 | 300,000 | Aug 09, 2018, 07:14 PM |
Adams Jonathan M | chief operating officer | Jul 27, 2017 | Option Exercise | $0.22 | 45,454 | 10,000 | 5,903,521 | Aug 09, 2018, 06:36 PM |
Sherman Michael Edward | Director | Jan 02, 2018 | Option Exercise | $0.15 | 200,000 | 30,000 | 268,181 | Aug 01, 2018, 04:26 PM |
Sherman Michael Edward | Director | Jul 03, 2018 | Option Exercise | $1.50 | 16,666 | 24,999 | 16,666 | Aug 01, 2018, 04:26 PM |
Sherman Michael Edward | Director | May 15, 2018 | Option Exercise | $0.02 | 250,000 | 4,500 | 518,181 | Aug 01, 2018, 04:26 PM |
Owner | Relationship | Date | Value($) |
GORLIN STEVE | Director | 12/01/2023 | 127,899 |
DO CUONG V | President & CEO | 11/30/2023 | 17,800 |
GORLIN STEVE | Director | 09/05/2023 | 26,108 |
BERMAN RICHARD J | Director | 08/22/2023 | 37,827 |
BERMAN RICHARD J | Director | 06/07/2023 | 34,782 |
BERMAN RICHARD J | Director | 05/22/2023 | 32,506 |
BERMAN RICHARD J | Director | 03/28/2023 | 64,870 |
BERMAN RICHARD J | Director | 03/27/2023 | 28,711 |
Palumbo Joseph M | Chief Medical Officer | 02/16/2023 | 15,153 |
DO CUONG V | CEO & President | 02/16/2023 | 30,312 |
KIM JOANNE WENDY | Chief Financial Officer | 02/16/2023 | 15,153 |
Ahlem Clarence N. | EVP Neuroscience Product Dev. | 02/16/2023 | 15,153 |
READING CHRISTOPHER | EVP Neuroscience R&D | 02/16/2023 | 15,153 |
MARKHAM PENELOPE | EVP Liver Cirrhosis R&D | 02/16/2023 | 15,153 |
PEIZER TERREN S | Director | 06/24/2019 | 68,685,030 |
PEIZER TERREN S | Director | 09/22/2020 | 155 |
PEIZER TERREN S | Director | 08/15/2022 | 6,000,001 |
KIM JOANNE WENDY | CFO | 12/07/2021 | 10,798 |
GORLIN STEVE | Director | 11/03/2020 | 19,318 |
GORLIN STEVE | Director | 10/30/2020 | 20,483 |
GORLIN STEVE | Director | 10/21/2020 | 45,950 |
GORLIN STEVE | Director | 10/15/2020 | 51,967 |
GORLIN STEVE | Director | 10/15/2020 | 100,550 |
GORLIN STEVE | Director | 10/09/2020 | 2,710 |
GORLIN STEVE | Director | 10/07/2020 | 44,444 |
GORLIN STEVE | Director | 09/22/2020 | 150,000 |
Kumar Hari | Director | 01/02/2019 | 7,000 |
Kumar Hari | Director | 06/15/2018 | 2,000 |
Kumar Hari | Director | 01/02/2018 | 30,000 |
Kumar Hari | Director | 08/14/2017 | 20,000 |
Adams Jonathan M | Chief Operating Officer | 01/02/2019 | 7,000 |
Sherman Michael Edward | Director | 01/02/2019 | 7,000 |
Do Cuong V | Director | 01/02/2019 | 7,000 |
Sooch Mina | Director | 01/02/2019 | 7,000 |
Lang James Paul | Director | 01/02/2019 | 7,000 |
Adams Jonathan M | Chief Operating Officer | 07/03/2018 | 15,000 |
Do Cuong V | Director | 07/03/2018 | 129,999 |
Lang James Paul | Director | 07/03/2018 | 30,000 |
Lang James Paul | Director | 01/02/2018 | 55,000 |
Lang James Paul | Director | 07/28/2017 | 25,000 |
Sooch Mina | Director | 04/30/2018 | 3,600 |
Sooch Mina | Director | 01/02/2018 | 30,000 |
Do Cuong V | Director | 01/02/2018 | 30,000 |
Do Cuong V | Director | 01/08/2018 | 25,000 |
Anderson Julie G | Director | 05/31/2018 | 1,096 |
Anderson Julie G | Director | 01/02/2018 | 30,000 |
Adams Jonathan M | chief operating officer | 07/27/2017 | 10,000 |
Sherman Michael Edward | Director | 01/02/2018 | 30,000 |
Sherman Michael Edward | Director | 07/03/2018 | 24,999 |
Sherman Michael Edward | Director | 05/15/2018 | 4,500 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 350,476 | 0.00001% | 388.68% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 187,589 | 0.00002% | 35.53% | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View